The study will investigate the role of 1,3-butadiene metabolic activation and deactivation in lung cancer risk among various ethnic/racial groups. This project will require urine samples from smokers and nonsmokers from the three ethnic/racial groups recruited by the Clinical and Biomarker Core for the analysis of 1,3-butadiene DNA adducts. Data on nicotine intake (urinary TNE) in these subjects as well as in 400 lung cancer cases and 400 controls from Project 1 will be also required for this project.
Study Type
OBSERVATIONAL
One to two home visits where tobacco use and medical history and biological samples will be collected including blood, buccal cells and urine
Butadiene-DNA adducts in different ethnic groups
Investigate ethnic differences in butadiene-DNA adducts in smokers belonging to different ethnic groups.
Time frame: Day 1 & 2
Butadiene-DNA adduct load in smokers with lung cancer
Investigate the association between butadiene-DNA adduct load and lung cancer development in smokers.
Time frame: Day 1 & 2
Polymorphisms of carnicogen metabolizing genes
Examine how polymorphisms of carcinogen metabolizing genes influence metabolic inactivation, DNA adduct formation/repair, and toxicity of butadiene-derived epoxides.
Time frame: Day 1 & 2
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.